Guggenheim Capital’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-103,966
| Closed | -$3.05M | – | 2901 |
|
|
2017
Q3 | $3.05M | Buy |
103,966
+18,147
| +21% | +$508K | 0.01% | 1371 |
|
|
2017
Q2 | $2.25M | Sell |
85,819
-30,397
| -26% | -$747K | 0.01% | 1540 |
|
|
2017
Q1 | $2.72M | Sell |
116,216
-25,303
| -18% | -$624K | 0.01% | 1423 |
|
|
2016
Q4 | $3.56M | Buy |
141,519
+115,898
| +452% | +$2.93M | 0.01% | 1227 |
|
|
2016
Q3 | $719K | Buy |
25,621
+71
| +0.3% | +$1.82K | ﹤0.01% | 2252 |
|
|
2016
Q2 | $630K | Buy |
25,550
+490
| +2% | +$12.2K | ﹤0.01% | 2279 |
|
|
2016
Q1 | $554K | Buy |
25,060
+6,770
| +37% | +$180K | ﹤0.01% | 2327 |
|
|
2015
Q4 | $640K | Sell |
18,290
-52,567
| -74% | -$1.65M | ﹤0.01% | 2322 |
|
|
2015
Q3 | $2.02M | Sell |
70,857
-4,307
| -6% | -$145K | 0.01% | 1584 |
|
|
2015
Q2 | $2.5M | Buy |
75,164
+2,138
| +3% | +$65.6K | 0.01% | 1586 |
|
|
2015
Q1 | $2.06M | Sell |
73,026
-311
| -0.4% | -$7.73K | ﹤0.01% | 1747 |
|
|
2014
Q4 | $1.52M | Sell |
73,337
-16,777
| -19% | -$398K | ﹤0.01% | 1945 |
|
|
2014
Q3 | $2.2M | Sell |
90,114
-1,974
| -2% | -$52.3K | 0.01% | 1696 |
|
|
2014
Q2 | $2.63M | Sell |
92,088
-9,608
| -9% | -$267K | 0.01% | 1588 |
|
|
2014
Q1 | $2.85M | Buy |
101,696
+1,399
| +1% | +$34.3K | 0.01% | 1497 |
|
|
2013
Q4 | $2.16M | Buy |
100,297
+5,715
| +6% | +$104K | 0.01% | 1722 |
|
|
2013
Q3 | $1.25M | Buy |
94,582
+7,679
| +9% | +$103K | ﹤0.01% | 1964 |
|
|
2013
Q2 | $1.2M | Buy |
+86,903
| New | +$1.23M | 0.01% | 1901 |
|
Guggenheim Capital's PMC Position: Q4 2017 in Review
Guggenheim Capital sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 103,966 shares — an estimated $3.05M sold.
Guggenheim Capital first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $3.56M in Q4 2016. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Guggenheim Capital reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Guggenheim Capital sold 103,966 PharMerica Corporation shares in Q4 2017, an estimated $3.05M.
- Guggenheim Capital first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Guggenheim Capital's PharMerica Corporation position peaked at $3.56M in Q4 2016.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Guggenheim Capital's 13F filing for Q4 2017, filed 14 Feb 2018.